|
Asia Looking to Europe’s HTAs for Guide on Containing Drug Costs
PHILADELPHIA – As Taiwan and South Korea increasingly use health technology assessment (HTA) to sift out the costs versus benefits of new drugs, other Asian countries, such as China, are looking at ways to adopt such cost-cutting programs, a pair of recent industry surveys suggests.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives